Cód QR

Cerebrospinal fluid NPTX2/p‐tau ratio as a biomarker for cognitive decline in neurodegenerative diseases

Abstract INTRODUCTION Neuronal pentraxin 2 (NPTX2) and its use as a ratio with other synaptic proteins has emerged as a prognostic cerebrospinal fluid (CSF) biomarker across neurodegenerative diseases. METHODS Using a single molecule array (Simoa) method, CSF NPTX2 was measured in 688 individuals fr...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Bárbara Fernandes Gomes, Mathias Sauer, Laia Montoliu‐Gaya, Maria Franquesa‐Mullerat, Alexandre Bejanin, Daniel Alcolea, Alberto Lleó, Ignacio Illán‐Gala, Juan Fortea, Kaj Blennow, Henrik Zetterberg, Johanna Nilsson, Olivia Belbin, Nicholas J. Ashton
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: Wiley 2026-04-01
Sraith:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Ábhair:
Alzheimer's disease
cerebrospinal fluid
cognitive decline
dementia with Lewy bodies
frontotemporal lobar degeneration
neuronal pentraxin 2
Rochtain ar líne:https://doi.org/10.1002/dad2.70391
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla